Message Encouraging Vaccination in Preparation for the Holidays
NCT05612360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520000
Last updated 2023-03-03
Summary
This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. Ther focal comparison in this experiment is between a message encouraging vaccination by reminding participants that the holiday season is just a few weeks away and getting vaccinated will allow them to more safely gather with loved ones and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination by reminding participants that the holiday season is just a few weeks away and getting vaccinated will allow them to more safely gather with loved ones will produce more vaccinations than otherwise identical messages.
Conditions
Interventions
- BEHAVIORAL
-
COVID Booster text messages
Participants will receive text messages per descriptions listed in the arms.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-03
- Primary Completion
- 2022-12-08
- Completion
- 2023-02-06
Countries
- United States
Study Locations
More Related Trials
-
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
NCT00744263 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
NCT00546572 ·Status: COMPLETED ·Phase: PHASE3
-
PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning
NCT06234683 ·Status: COMPLETED ·Phase: NA
-
Pneumonia Vaccine Education Intervention Study
NCT06136832 ·Status: COMPLETED ·Phase: NA
-
PreTeenVax Evaluation
NCT03186430 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00370227 ·Status: COMPLETED ·Phase: PHASE3
-
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants
NCT04382326 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
NCT05489328 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2
NCT04887948 ·Status: COMPLETED ·Phase: PHASE3
-
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
NCT04398706 ·Status: COMPLETED ·Phase: PHASE2
-
Pneumococcal Vaccines in Patients With Asthma
NCT03260790 ·Status: COMPLETED ·Phase: PHASE4
-
Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.
NCT02124161 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Safety, Tolerability and Immunogenicity of 13vPnC as a 2-Dose Regimen or With 23vPS
NCT00574548 ·Status: COMPLETED ·Phase: PHASE3
-
P3+ Intervention Phase
NCT02898688 ·Status: COMPLETED ·Phase: NA
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults
NCT00427895 ·Status: COMPLETED ·Phase: PHASE3
-
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children
NCT04275284 ·Status: COMPLETED
-
Conectados: Social Networks and Social Media for Vaccine Uptake
NCT07096245 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults
NCT03760146 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants
NCT03512288 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose.
NCT01026038 ·Status: COMPLETED ·Phase: PHASE3
-
Puerto Rico COVID-19 Vaccine Uptake Study
NCT05468021 ·Status: UNKNOWN ·Phase: NA
-
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
NCT07348692 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
NCT06824181 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults
NCT03828617 ·Status: COMPLETED ·Phase: PHASE3